Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.570 | 1.000 | 7 | 2 | 2006 | 2016 | |||||||||
|
protein phosphatase 1 catalytic subunit beta | 0.601 | 0.577 | 1.00 |
|
disease | 0.350 | 1.000 | 5 | 0 | 2016 | 2019 | |||||||||
|
mitogen-activated protein kinase kinase 2 | 0.534 | 0.731 | 0.97 |
|
disease | 0.540 | 1.000 | 4 | 0 | 2007 | 2016 | |||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.640 | 1.000 | 4 | 3 | 2006 | 2018 | |||||||||
|
SOS Ras/Rac guanine nucleotide exchange factor 1 | 0.485 | 0.808 | 1.00 |
|
disease | 0.330 | 1.000 | 3 | 1 | 2008 | 2012 | |||||||||
|
actin alpha 1, skeletal muscle | 0.540 | 0.769 | 1.1E-06 |
|
disease | 0.530 | 1.000 | 3 | 0 | 2001 | 2013 | |||||||||
|
checkpoint kinase 1 | 0.492 | 0.808 | 3.1E-08 |
|
disease | 0.320 | 1.000 | 2 | 0 | 2003 | 2010 | |||||||||
|
mutY DNA glycosylase | 0.521 | 0.769 | 1.3E-18 |
|
disease | 0.320 | 0.500 | 2 | 0 | 2009 | 2017 | |||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.520 | 1.000 | 2 | 0 | 2014 | 2016 | |||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.310 | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
RAS p21 protein activator 1 | 0.481 | 0.885 | 1.00 |
|
disease | 0.310 | 1.000 | 1 | 2 | 2010 | 2010 | |||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.310 | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
desmoplakin | 0.514 | 0.808 | 1.00 |
|
disease | 0.310 | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
SHOC2 leucine rich repeat scaffold protein | 0.593 | 0.769 | 1.00 |
|
disease | 0.310 | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 1.000 | limited | 0.982 | 1872 | 14 | 1992 | 2020 | ||||||||
|
huntingtin | 0.548 | 0.654 | 1.00 |
|
disease | 1.000 | limited | 0.987 | 1271 | 3 | 1993 | 2020 | ||||||||
|
C9orf72-SMCR8 complex subunit | 0.496 | 0.769 | 1.1E-06 |
|
disease | 0.800 | limited | 0.985 | 512 | 3 | 2009 | 2020 | ||||||||
|
C9orf72-SMCR8 complex subunit | 0.496 | 0.769 | 1.1E-06 |
|
disease | 0.500 | limited | 0.987 | 374 | 2 | 2011 | 2020 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.700 | limited | 0.993 | 268 | 7 | 1999 | 2020 | ||||||||
|
triggering receptor expressed on myeloid cells 2 | 0.519 | 0.769 | 3.3E-09 |
|
disease | 0.700 | limited | 0.977 | 211 | 13 | 2007 | 2020 | ||||||||
|
age-related maculopathy susceptibility 2 | 0.670 | 0.308 | 5.2E-04 |
|
disease | 0.700 | limited | 0.951 | 164 | 8 | 2005 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
phenotype | 1.000 | limited | 0.995 | 158 | 12 | 1997 | 2020 | ||||||||
|
cytochrome b-245 beta chain | 0.452 | 0.885 | 1.00 |
|
group | 0.900 | limited | 0.986 | 143 | 6 | 1987 | 2020 | ||||||||
|
HtrA serine peptidase 1 | 0.532 | 0.692 | 4.9E-04 |
|
disease | 0.500 | limited | 0.940 | 129 | 9 | 2006 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.600 | limited | 0.984 | 122 | 1 | 2002 | 2020 |